Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$345,775
+$25,134 QoQ
Shares Held
162,336
-14.4% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 108 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Derivatives in ALDX
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$15,540
PutShares
3,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ALDX ranks #209 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ALDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,775 | 162,336 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $320,641 | 189,729 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $15,540 | 3,000 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $1,896,754 | 366,169 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,886,867 | 361,469 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,394,765 | 364,169 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,257,058 | 392,532 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,964,331 | 393,654 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,082,187 | 386,306 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,308,432 | 395,297 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,266,482 | 387,304 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,211,345 | 345,113 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,293,055 | 343,272 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,851,559 | 339,876 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,699,400 | 271,843 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,212,214 | 317,847 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,657,566 | 310,406 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,322,113 | 331,357 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,469,235 | 330,537 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $946,560 | 236,640 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,278,065 | 259,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,595,580 | 140,828 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $887,150 | 74,676 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $49,755 | 7,253 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,756 | 237 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,147 | 515 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $41,374 | 16,751 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||